Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on X:
“It’s Friday round table in my office and the buzz is real. Riveting discussions on the latest and greatest in drug development with amazing trail blazing colleagues: breast cancer Erika Hamilton, lymphoma Krish Patel melanoma Meredith McKean GU cancers Benjamin Garmezy -Post-ASCO pre-ESMO, and everything in between. The future of of oncology drugs is unfolding in real time.”